A predictive model for psoriasis relapse risk demonstrates moderate performance, according to results of a recent study.

Antoni Ribas, MD, PhD: For certain cancers where we know it can only work in a specific situation that has a specific marker, having a companion diagnostic makes a lot of sense. You want to select ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify [email protected] if there are concerns regarding accuracy of the transcription.

CHICAGO--(BUSINESS WIRE)--Tempus, a leader in artificial intelligence and precision medicine, today announced its new DPYD algorithm as its most recent addition to its growing collection of predictive ...

A randomized phase 2 study of enhanced AR blockade with enzalutamide in high-risk patients with biochemical relapse undergoing salvage radiation: Final results from RTOG 3506 (STEEL). This is an ASCO ...